Alternatively, erastin may promote FtH transcription through the activation of the transcriptional factor Nrf-2 or through the downregulation of YAP pathway as very recently demonstrated in hepatocellular carcinoma and lung adenocarcinoma, respectively (13, 56). This evidence concerns the gene FTH1 and hepatocellular carcinoma.